NATURE’S SUNSHINE PRODUCTS, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$3.11 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-16.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2023-03-16
- NATURE’S SUNSHINE PRODUCTS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2019-03-31 was -$316.00K.
- NATURE’S SUNSHINE PRODUCTS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2018-03-31 was -$213.00K, a 123.36% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2017-12-31 was $640.00K.
- NATURE’S SUNSHINE PRODUCTS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2017-09-30 was $113.00K, a 86.39% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$3.11M.
- NATURE’S SUNSHINE PRODUCTS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2021 was -$250.00K, a 119.69% decline from fiscal 2020.
- NATURE’S SUNSHINE PRODUCTS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2020 was $1.27M.
- NATURE’S SUNSHINE PRODUCTS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2019 was -$118.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$3.11M 10-K · filed 2023-03-16 | |||
| 2021-12-31 | -$250.00K 10-K · filed 2023-03-16 | |||
| 2020-12-31 | $1.27M 10-K · filed 2022-03-08 | |||
| 2019-12-31 | -$118.00K 10-K · filed 2021-03-10 | |||
| 2019-03-31 | -$316.00K 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | -$975.00K 10-K · filed 2020-03-11 | |||
| 2018-03-31 | -$213.00K 10-Q · filed 2018-05-10 | $427.00K derived: sum of 2 quarters · filed 2019-03-08 | $540.00K derived: sum of 3 quarters · filed 2019-03-08 | $3.00K derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-12-31 | $640.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $753.00K derived: sum of 2 quarters · filed 2019-03-08 | $216.00K derived: sum of 3 quarters · filed 2019-03-08 | $1.13M 10-K · filed 2019-03-08 |
| 2017-09-30 | $113.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$424.00K derived: sum of 2 quarters · filed 2017-11-09 | $488.00K 10-Q · filed 2017-11-09 | -$837.00K derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-06-30 | -$537.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $375.00K 10-Q · filed 2017-08-09 | -$950.00K derived: sum of 3 quarters · filed 2019-03-08 | -$120.00K derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-03-31 | $912.00K 10-Q · filed 2017-05-10 | -$413.00K derived: sum of 2 quarters · filed 2019-03-08 | $417.00K derived: sum of 3 quarters · filed 2019-03-08 | $958.00K derived: sum of 4 quarters · filed 2019-03-08 |
| 2016-12-31 | -$1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | -$495.00K derived: sum of 2 quarters · filed 2019-03-08 | $46.00K derived: sum of 3 quarters · filed 2019-03-08 | -$17.00K 10-K · filed 2019-03-08 |
| 2016-09-30 | $830.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.37M derived: sum of 2 quarters · filed 2016-11-09 | $1.31M 10-Q · filed 2016-11-09 | $1.05M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | $541.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $478.00K 10-Q · filed 2016-08-09 | $216.00K derived: sum of 3 quarters · filed 2018-03-16 | $850.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | -$63.00K 10-Q · filed 2016-05-10 | -$325.00K derived: sum of 2 quarters · filed 2018-03-16 | $309.00K derived: sum of 3 quarters · filed 2018-03-16 | -$103.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | -$262.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $372.00K derived: sum of 2 quarters · filed 2018-03-16 | -$40.00K derived: sum of 3 quarters · filed 2018-03-16 | -$39.00K 10-K · filed 2018-03-16 |
| 2015-09-30 | $634.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $222.00K derived: sum of 2 quarters · filed 2015-11-06 | $223.00K 10-Q · filed 2015-11-06 | $3.13M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | -$412.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$411.00K 10-Q · filed 2015-08-10 | $2.49M derived: sum of 3 quarters · filed 2017-03-14 | |
| 2015-03-31 | $1.00K 10-Q · filed 2015-05-11 | $2.90M derived: sum of 2 quarters · filed 2017-03-14 | ||
| 2014-12-31 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $2.76M 10-K · filed 2017-03-14 | ||
| 2014-09-30 | -$145.00K 10-Q · filed 2014-11-06 | |||
| 2013-12-31 | -$3.40M 10-K · filed 2016-03-14 | |||
| 2012-12-31 | -$497.00K 10-K · filed 2015-03-13 | |||
| 2011-12-31 | -$2.42M 10-K · filed 2014-03-17 | |||
| 2010-12-31 | $11.95M 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |